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1064-151 Outcomes of Patients Removed From a Cardiac 
Transplant Waiting List: Implications for Maximizing a 
Scarce Resource 
Katherine J. Hoercher, Patrick M. McCarthy, Eugene H. Blackstone, Michael K. Banbury, 
Nicholas G. Smedira, Jose L. Navia, James B. Young, C/eve/and C/inic Foundation, 
Cleveland, Ohio. 
Background and Purpose: The continued shortage of organ donors has mandated a goal 
of both reduction of the waiting list and limiting cardiac transplantation (Tx) to those most 
likely to achieve the greatest benefit. This study analyzes the impact of removal of 
patients (pts) from the waiting list on both mortality and identification of its determinants. 
Methods: Data was reviewed on pts listed for Tx at a single center over an eleven year 
pedod between 1989 and 2000. Review of our heart transplant database was supple- 
mented with chart analysis and telephone follow-up with pts or cardiologists. Of this 
group, 21 pts were lost to follow-up. Muitivadable analysis of time-relatad survival used 
bootstrap bagging. Results:177 pts were removed from the waiting list; 73 pts are cur- 
renUy alive and 83 died following removal. Mean follow-up is 4.2 years. The most com- 
mon reason for removal was medical improvement (55%), followed by psychosocial 
contraindicetions (16%), medically unsuitable (15%), and transfer to another Tx center 
(10%). Survival is 78%, 45%, and 25% at 1, 5, and 10 years respectively after removal. 
Survivors were largely NYHA class I (48%) or II (30%), 13 pts were relisted and 12 trans- 
planted. 8 pts underwent partial eft ventriculectomy as a surgical alternative to Tx. A his- 
tory of malignant ventricular arrhythmia was identified in 40/83 deceased pts with 
subsequent sudden death the most common known cause of mortality (19%). Overall, 
pts removed secondary to clinical improvement had the most favorable eady survival 
(89% at 1 yr), versus the medically unsuitable, who had the least favorable survival (11% 
at I yr). Conclusion: In the subset of pts delisted secondary to clinical improvement, opti- 
mization of pharmacological therapy and the use of alternative surgical therapies has 
resulted in an acceptable 1 year survival. This finding has the potential to identify pts cur- 
renUy listed for transplant who are unlikely to gain survival benefit from the procedure 
and maximizes use of limited organ resources. The results also suggest that given the 
risk for sudden death in this heart failure population, electrophysiology studies and AICD 
implantation should be considered prior to removal. 
1064-152 Clinical Risk Factors for Development of Nonlymphoma 
Cancer Poat-Heart and Heart-Lung Transplantation: 
Analysis of 30-Year Follow-Up in 1,026 Patients 
Shao-Zhou Gao. Mark G. Perlroth, Jose G. Montoya, Joan L. Miller, Sue DiMiceli, Bill 
Brown, Phillip E. Oyer, John S. Schroeder, Stanford University School of Medicine, 
Stanford, Califomia. 
Background: The use of immunosuppressive r gimens for organ transplantation (Tx) is 
associated with increased frequency of malignancy. We examined the incidence of non- 
lymphoma cancers (NLC) among heart (H) and heart-lung (H-L) Tx recipients and identi- 
fied potential predisposing factors. 
Methods: Between 1968 - 1997 1026 patients underwent H (874) or H-L (152) Tx. 122 
heart, and 7 heart-tung Tx recipients (12,6%) developed NLC. Four regimens (cohort 1- 
4)were used. 1: Pradnisone (PRED), Azathiopdne (AZA); 2: PRED, AZA, Cyclosporine 
(CyA) 3: PRED, AZA, CyA, OK'I'3, ganciclovir; 4: OKT3, ganciclovir, tacrolimus, rnyco- 
phenolata, Risk factors evaluated included age, gender, HLA, prior cardiac diagnosis, 
CMV infection, rejection, genciclovir, and calcium channel blocker use. 
Results: No correlation of NLC was found with four different regimens. Older recipient 
age, male gender, and frequency of rejection episodes correlated with NLC development. 
Those receiving ganciclovir prophylaxis, compared with all other H and H-L Tx recipients, 
had less NLC (p<0.05), Calcium channel blockers had no effect. 38 patients had 2 or 
more NLC. Actuarial frequency of NLC was 30% at 13,3 years. 
Conclusion: Modification of pest-transplantation immunosuppressive regimens did not 
alter NLC incidence. Recipient age, male gender and rejection frequency were associ- 
ated with increased NLC development. NLC prevalence reached 30% 13.3 years after 
Tx. 
1.0e ~ 
u, 
.gO Cohort 
.85 4,N 
+ 4.14-cmlS~od 
"80 "" 3.00 
~Q- .75 " 3.N-centmred 
30 a 2,00 
o 2.N-cenlmf ed
v 1.0~¢ enletH 
t4 2 4 $ | 10 12 
Years 
JACC March 6, 2002 
POSTER SESS ION 
1065 Determining Cardiovascular Risk in the 
Elderly 
Sunday, March 17, 2002, 3:00 p.m.-5:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 3:00 p.m.-4:00 p.m. 
1065-141 The Morphology of Aort ic Valve Sclerosis Predicts 
Cardiovascular Disease 
Kirstan Tolstruo, Carlos A. Roldan, Michael H. Crawford, Veterans Affairs Medical 
Center, Albuquerque, New Mexico, Cedars-Sinai Medical Center, Los Angeles, 
California. 
Background: Aortic valve sclerosis (AVS) detected by transthoracic echocardiography is
associated with cardiovascular morbidity and mortality. Since it is not cost effective to test 
all patients (pts) with AVS for cardiovascular disease (CVD), the identification of paUents 
at highest dsk is important. We sought to develop a morphologic lassification of AVS by 
transesophageal echocerdiography (TEE) that may identify patients at highest risk. We 
correlated the types of AVS with CVD defined as coronary artery disease, carotid artery 
disease, or peripheral vascular disease. 
Methods: A total of 173 pts age > 50 years (mean 67 ± 9 years) underwent TEE, TEE's 
were interpreted by two experienced observers blinded to the patient's clinical data. The 
aortic valve was defined as normal (_< 2ram), mildly (2-4ram), or moderately (> 4-6ram) 
sclerotic. Valve sclerosis was classified as: Type I (localized, non-nodular), type II (local- 
ized, nodular), type III (diffuse), and type IV (mixed type). 
Results: Of the 173 pts, 72 (42%) had AVS, The morphologic distribution was: Type I, 
n=5 (7%); type II, n=7 (10%); type III, n= 23 (32%); and type IV, n=37 (51%). Of the 37 
pts with mixed AVS (type IV), 29 had mixed nodular and diffuse sclerosis. AVS in general 
was not associated with CVD. However, the 29 pts with mixed nodular and diffuse AVS 
had significantly more CVD (p=0.05), coronary artery disease (p=0.05), and history of 
CABG (p= 0.004) (OR 3, 3, and 7, respectively). Also, when compared with age, hyper- 
tension, diabetes, smoking, and hypercholesterolemia, this mixed type of AVS was the 
only independent predictor for CVD by stepwise logistic regression analysis. 
Conclusions: In patients over 50 years with aortic valve sclerosis, the finding of a mix of 
nodular and diffuse sclerosis identifies those at increased risk for cardiovascular disease. 
Thus, these patients need further evaluation. 
1065-142 Stratification of Risk for  a First Cardiovascular Event in 
the Elderly: Importance of Echocardiography 
Teresa S. Tseng, Kent R. Bailey, Marion E. Barnes, Yasuhiko Takemoto, Aaron Terry, 
Sanderson A. Cauduro. James B. Seward, Mayo Clinic, Rochester, Minnesota. 
Background: The risks for myocardial infarction (MI), need for coronary revasculariza- 
t/on procedures (CR), congestive heart failure (CHF), atrial fibrillation (AF), transient 
ischemic attack (TIA) and stroke increase with age. Primary prevention of these events 
requires accurate risk stratification. 
Methods: The study population consisted of a random sample of Olmstad County, MN 
patients aged >65 years who underwent echocardiography in 1990-98. Eligible patients 
were those in sinus rhythm, and free from a history of MI, CR, CHF, AF, TIA and stroke. 
Using Cox regression, we examined the clinical, ECG, and echocardlographic (echo) 
predictors of the composite endpoint of these aforementioned events. 
Result:;: The study included 1,297 patients (494 men; 803 women), mean age 74 + 7 
years. Newly developed events during the follow-up time of 4.5 ± 2.7 years included 93 
MI, 115 CR, 109 CHF, 109 AF, 41 TIA, and 76 strokes. The number of patients who had 
>1 event was 368 (28%), and 338 (26%) died. For prediction of the composite endpoint, 
the significant non-echo variables were age (Z2=49), hypertension (;(2=24), diabetes 
(Z2=8), and ECG left ventdcular hypertrophy (Z2=5). The echo predictors were left atrial 
volume indexed to body surface area (Z2=34), diastolic function grade (Z2=29), left ven- 
tricular mass indexed to height (X2=33), and left ventricular ejection fraction (Z2= 12), all 
P<0.05. When all 4 echo variables were considered together, each was independently 
significant, with total model Z2=79. When both non-echo and echo variables were 
entered simultaneously in a multiple Cox regression model, all but ECG left ventricular 
hypertrophy remained independently predictive of risk for the composite endpelot, model 
;(2=143. A composite clinical/echo score was dedved, based on these 7 variables, which 
yielded 9 risk groups with 5-year Kaplan-Meier event rates of 6%, 7%, 18%, 28%, 31%, 
33%, 36%, 48%, and 74%. An analogous echo score produced 7 risk groups with 5-year 
event rates of 3%, 14%, 21%, 28%, 35%, 37%, and 58%. 
Conclusion: The 5-year risk of age-related cardiac events was high in this group of eld- 
erly patients. Echocardiography was incremental to clinical data in stratification of risk for 
a first event. 
1065-143 Mycopiasma Pneumonias in Calcified Aort ic Valves 
Humberto P/err/, Mar/lie H. Santos, Maria L. Hiauchi, Marcia M. Re/s, Nadia V. 
Sambiase, Lea M. Demamhi, Jose A. Ramires, Mauricio Wanjgarten, Heart Institute 
School of Medicine, Sac Paulo, Brazil. 
Background - Calcification in stenotic aortic valves (SAO) has been considered as an 
atheroscleretic process by some authors. However this concept is controversial as many 
patients with systemic severe atherosclerosis do not present aortic stenosis. We have 
recently found Mycoplasma pneumoniae (MP) in atherosclerotic plaques. Mycoplasmas 
are the only bactada that present high content of cholesterol in their membrane. Hera we 
hypothesized that high amounts of lipids due to MP membrane accumulation are present 
in aortic valves AV favodng deposition of calcium. Methods - For detection of MP we 
used the electron microscopy and "in situ' hybridization (ISH) techniques. A quantitative 
